NCT07114809

Brief Summary

Cognitive impairment (CI) affects a large amount of patients with Multiple Sclerosis (PwMS) even in the early stages of the disease, increasing the perception of fatigue and compromising the quality of life. Different restorative interventions have been tried in order to alleviate CI, but with limited efficacy . Transcranial direct current stimulation (tDCS), represents a very promising alternative, or add-on, to the traditional rehabilitative approaches in MS. Notably, other novel technologies, such as Virtual Reality (VR) and Exergame, are emerging as a reinforcing tool to the rehabilitative treatment of PwMS. tDCS and VR can be combined in protocols aimed at achieving a better therapeutic benefit across different neurological diseases (Cassani 2020). The aim of our project is to explore the potential benefits of the simultaneous application of AtDCS and VR in the rehabilitation of cognitive impairment of PwMS. The VR approach will be implemented with a non-immersive VR system (exergames). As a secondary outcome, we wish to verify whether our protocol may extend its benefits over 6 months. Eighty PwMs with CI will be consecutively enrolled. Their cognitive status will be assessed by a neuropsychological battery: the Brief International Cognitive Assessment for MS and the Paced Auditory Serial Addition Test. To be considered cognitively impaired one has to abnormally score on at least two tests. Forty patients will be randomized to the experimental group (EG) or to the control group (CG). All the patients will undergo rehabilitative treatment with exergame (10 sessions for two consecutive weeks, 5 days per week). The EG patients will undergo a concurrent A-tDCS over the left dorsolateral prefrontal cortex, while the CG will receive a sham stimulation (S-tDCS). The patients will be evaluated at baseline, at the end of the treatment, one month and six months later. The statistical analyses will be done using repeated-measures ANOVA. Expected results: we hypothesize that the cognitive performances of both EG and CG groups will show an improvement in the cognitive performances. We will expect, however, a significative difference between the two groups, with patients in the EG group demonstrating better results than the CG group. Finally, we hypothesize the beneficial effects in EG patients will last at least one month after the end of the experiment.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 2, 2024

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 11, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

August 11, 2025

Status Verified

August 1, 2025

Enrollment Period

1.3 years

First QC Date

August 4, 2025

Last Update Submit

August 4, 2025

Conditions

Keywords

Cognitive impairmentMultiple SclerosisExergaimingVirtual RealitytDCS

Outcome Measures

Primary Outcomes (4)

  • Revised Brief Visuo-Spatial Memory test (BVMT-R)

    Part of the BICAMS test. minimum score 0 (poor performance) maximum score 12 (normal performance)

    The patients will be evaluated at baseline, up to two weeks, one month and six months later

  • Symbol digit modalities test (SDMT)

    Part of the BICAMS test. minimum score 0 (poor performance), maximum score 120 (normal performance)

    The patients will be evaluated at baseline, up to two weeks, one month and six months later.

  • California Verbal Learning test II edition (CVLT-II)

    Part of the BICAMS test. Minimum score 0 (poor performance), maximum score 80 (normal performance)

    The patients will be evaluated at baseline, up to two weeks, one month and six months later

  • Paced Auditory Serial Addition Task 3" and 2" intervals (PASAT)

    A neuropsychological test widely utilized for the cognitive assessment in PwMS. Minimum score 0 (poor performance) maximum score 60 (normal performance)

    The patients will be evaluated at baseline, up to two weeks, one month and six months later

Secondary Outcomes (3)

  • Multiple Sclerosis Quality of life (MSQoL)

    The patients will be evaluated at baseline, up to two weeks, one month and six months later

  • Beck depression inventory scale (BDI)

    The patients will be evaluated at baseline, up to two weeks, one month and six months later

  • Fatigue Severity Scale (FSS)

    The patients will be evaluated at baseline, up to two weeks, one month and six months later

Study Arms (2)

Experimental group (EG) performing Anodal-tDCS (A-tDCS) and VR

EXPERIMENTAL

EG subjects will undergo a rehabilitative treatment with exergame and concurrent A-tDCS over the left dorsolateral prefrontal cortex.

Device: Experimental group (EG) performing Anodal-tDCS (A-tDCS) and VR

Control group (CG) performing sham-tDCS (S-tCDS) and VR

SHAM COMPARATOR

CG subjects will undergo a rehabilitative treatment with exergame and concurrent S-tDCS over the left dorsolateral prefrontal cortex.

Device: Sham Comparator: Control group (CG) performing sham-tDCS (S-tCDS) and VR

Interventions

Patients in the EG group will undergo a simultaneous A-tDCS over the left DLFPC. The tDCS will be delivered by a battery-driven, constant current simulator, two holding bags of plant cellulose (7x5 cm) and two electrodes of conductive silicone. The active (anodal) electrode will be placed by means of a cap on the scalp overlying the left DLPFC (46 Brodmann Area). The reference electrode will be located over the right shoulder. The choice of the left DLPFC as the site of stimulation relies upon the evidence that this region has a critical role in the "top-down" control of the task-relevant stimuli processing (Miller 2001).The DLPFC contributes to increase cognitive control through its connections with the anterior cingulate cortex and has been shown to enhance working memory and executive function. During the cognitive training (on-line procedure), A-tDCS (current of 1,5 mA) will be delivered for 20 minutes, while maintaining the current density (0.06 mA/cm2) below the safety limits.

Experimental group (EG) performing Anodal-tDCS (A-tDCS) and VR

CG will receive a S-tDCS over the DLPFC. In the S-tDCS session, the current will be turned off 30 sec after the beginning of the stimulation and turned on for the last 30 sec. By doing this, the patient feels an itching sensation below the electrodes at the beginning and at the end of stimulation, making this condition indistinguishable from the real A-tDCS stimulation. Doing this, all the subjects will be blinded on the type of stimulation. As well as in the EG, CG performs cognitive training including motor and cognitive exergames that incorporate enjoyment, technology, and health care.

Control group (CG) performing sham-tDCS (S-tCDS) and VR

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • MS diagnosis according to McDonald's criteria (McDonald 2017);
  • age between 18 and 60 (to avoid participants with possible CI due to aging); 3) disability score ≤7.5 at the Expanded Disability Status Scale (EDSS, Kurtzke 1983).

You may not qualify if:

  • subjects affected by major psychiatric disorders
  • epilepsy
  • previous brain surgery
  • MS relapse requiring steroid therapy in the previous two months
  • bilateral visual acuity \< 6/10

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Azienda Sanitaria Genovese

Genova, Italy, 16100, Italy

RECRUITING

Ospedale Policlinico San Martino - IRCCS

Genova, Italy, 16132, Italy

RECRUITING

Italian multiple sclerosis foundation

Genova, Italy, 16149, Italy

RECRUITING

Related Publications (21)

  • Laver KE, George S, Thomas S, Deutsch JE, Crotty M. Virtual reality for stroke rehabilitation. Cochrane Database Syst Rev. 2015 Feb 12;2015(2):CD008349. doi: 10.1002/14651858.CD008349.pub3.

    PMID: 25927099BACKGROUND
  • Cassani R, Novak GS, Falk TH, Oliveira AA. Virtual reality and non-invasive brain stimulation for rehabilitation applications: a systematic review. J Neuroeng Rehabil. 2020 Oct 31;17(1):147. doi: 10.1186/s12984-020-00780-5.

    PMID: 33129331BACKGROUND
  • Solari A, Filippini G, Mendozzi L, Ghezzi A, Cifani S, Barbieri E, Baldini S, Salmaggi A, Mantia LL, Farinotti M, Caputo D, Mosconi P. Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):158-62. doi: 10.1136/jnnp.67.2.158.

    PMID: 10406981BACKGROUND
  • Poreisz C, Boros K, Antal A, Paulus W. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull. 2007 May 30;72(4-6):208-14. doi: 10.1016/j.brainresbull.2007.01.004. Epub 2007 Jan 24.

    PMID: 17452283BACKGROUND
  • Charvet L, Shaw M, Dobbs B, Frontario A, Sherman K, Bikson M, Datta A, Krupp L, Zeinapour E, Kasschau M. Remotely Supervised Transcranial Direct Current Stimulation Increases the Benefit of At-Home Cognitive Training in Multiple Sclerosis. Neuromodulation. 2018 Jun;21(4):383-389. doi: 10.1111/ner.12583. Epub 2017 Feb 22.

    PMID: 28225155BACKGROUND
  • Mattioli F, Bellomi F, Stampatori C, Capra R, Miniussi C. Neuroenhancement through cognitive training and anodal tDCS in multiple sclerosis. Mult Scler. 2016 Feb;22(2):222-30. doi: 10.1177/1352458515587597. Epub 2015 May 26.

    PMID: 26014600BACKGROUND
  • Filippi M, Riccitelli G, Mattioli F, Capra R, Stampatori C, Pagani E, Valsasina P, Copetti M, Falini A, Comi G, Rocca MA. Multiple sclerosis: effects of cognitive rehabilitation on structural and functional MR imaging measures--an explorative study. Radiology. 2012 Mar;262(3):932-40. doi: 10.1148/radiol.11111299.

    PMID: 22357892BACKGROUND
  • Mainero C, Caramia F, Pozzilli C, Pisani A, Pestalozza I, Borriello G, Bozzao L, Pantano P. fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. Neuroimage. 2004 Mar;21(3):858-67. doi: 10.1016/j.neuroimage.2003.10.004.

    PMID: 15006652BACKGROUND
  • Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000 Sep 15;527 Pt 3(Pt 3):633-9. doi: 10.1111/j.1469-7793.2000.t01-1-00633.x.

    PMID: 10990547BACKGROUND
  • Hiew S, Nguemeni C, Zeller D. Efficacy of transcranial direct current stimulation in people with multiple sclerosis: a review. Eur J Neurol. 2022 Feb;29(2):648-664. doi: 10.1111/ene.15163. Epub 2021 Nov 19.

    PMID: 34725881BACKGROUND
  • Grigorescu C, Chalah MA, Lefaucheur JP, Kumpfel T, Padberg F, Ayache SS, Palm U. Effects of Transcranial Direct Current Stimulation on Information Processing Speed, Working Memory, Attention, and Social Cognition in Multiple Sclerosis. Front Neurol. 2020 Oct 15;11:545377. doi: 10.3389/fneur.2020.545377. eCollection 2020.

    PMID: 33178103BACKGROUND
  • Nascimento AS, Fagundes CV, Mendes FADS, Leal JC. Effectiveness of Virtual Reality Rehabilitation in Persons with Multiple Sclerosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Mult Scler Relat Disord. 2021 Sep;54:103128. doi: 10.1016/j.msard.2021.103128. Epub 2021 Jul 9.

    PMID: 34280679BACKGROUND
  • Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, Reiss AL, Greicius MD. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. 2007 Feb 28;27(9):2349-56. doi: 10.1523/JNEUROSCI.5587-06.2007.

    PMID: 17329432BACKGROUND
  • McNicholas N, O'Connell K, Yap SM, Killeen RP, Hutchinson M, McGuigan C. Cognitive dysfunction in early multiple sclerosis: a review. QJM. 2018 Jun 1;111(6):359-364. doi: 10.1093/qjmed/hcx070.

    PMID: 28371862BACKGROUND
  • Fregni F, Boggio PS, Nitsche M, Bermpohl F, Antal A, Feredoes E, Marcolin MA, Rigonatti SP, Silva MT, Paulus W, Pascual-Leone A. Anodal transcranial direct current stimulation of prefrontal cortex enhances working memory. Exp Brain Res. 2005 Sep;166(1):23-30. doi: 10.1007/s00221-005-2334-6. Epub 2005 Jul 6.

    PMID: 15999258BACKGROUND
  • De Giglio L, De Luca F, Prosperini L, Borriello G, Bianchi V, Pantano P, Pozzilli C. A low-cost cognitive rehabilitation with a commercial video game improves sustained attention and executive functions in multiple sclerosis: a pilot study. Neurorehabil Neural Repair. 2015 Jun;29(5):453-61. doi: 10.1177/1545968314554623. Epub 2014 Nov 14.

    PMID: 25398725BACKGROUND
  • Dardiotis E, Nousia A, Siokas V, Tsouris Z, Andravizou A, Mentis AA, Florou D, Messinis L, Nasios G. Efficacy of computer-based cognitive training in neuropsychological performance of patients with multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord. 2018 Feb;20:58-66. doi: 10.1016/j.msard.2017.12.017. Epub 2017 Dec 24.

    PMID: 29306740BACKGROUND
  • Manuli A, Maggio MG, Tripoli D, Gulli M, Cannavo A, La Rosa G, Sciarrone F, Avena G, Calabro RS. Patients' perspective and usability of innovation technology in a new rehabilitation pathway: An exploratory study in patients with multiple sclerosis. Mult Scler Relat Disord. 2020 Sep;44:102312. doi: 10.1016/j.msard.2020.102312. Epub 2020 Jun 18.

    PMID: 32585618BACKGROUND
  • Lang N, Siebner HR, Ward NS, Lee L, Nitsche MA, Paulus W, Rothwell JC, Lemon RN, Frackowiak RS. How does transcranial DC stimulation of the primary motor cortex alter regional neuronal activity in the human brain? Eur J Neurosci. 2005 Jul;22(2):495-504. doi: 10.1111/j.1460-9568.2005.04233.x.

    PMID: 16045502BACKGROUND
  • Taylor MJ, Griffin M. The use of gaming technology for rehabilitation in people with multiple sclerosis. Mult Scler. 2015 Apr;21(4):355-71. doi: 10.1177/1352458514563593. Epub 2014 Dec 22.

    PMID: 25533296BACKGROUND
  • Vestito L, Schenone C, Casazza F, Modenesi R, Iandolino A, Matichecchia MG, Saez LM, Botto M, Ponzano M, Gazzola P, Grange E, Brichetto G, Bandini F, Trompetto C, Mori L. Impact of anodal tDCS and virtual reality on cognitive dysfunction in patients with Multiple Sclerosis: Protocol of a double blind, randomized, prospective, controlled study. PLoS One. 2025 Dec 4;20(12):e0337405. doi: 10.1371/journal.pone.0337405. eCollection 2025.

MeSH Terms

Conditions

Cognitive DysfunctionMultiple Sclerosis

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Laura Mori, MD, PhD

    Ospedale Policlinico San Martino IRCCS

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: double blind, randomized, controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2025

First Posted

August 11, 2025

Study Start

September 2, 2024

Primary Completion

January 1, 2026

Study Completion

January 1, 2026

Last Updated

August 11, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

At this time, individual participant data (IPD) will not be shared due to concerns regarding patient confidentiality and the challenges of fully anonymizing sensitive clinical and neuropsychological data. In addition, data sharing is not currently covered by participant informed consent and would require additional ethical and regulatory approvals to ensure compliance with privacy laws and institutional policies.

Locations